Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Effect of improved navigation performance on the accuracy of implant placement in total hip arthroplasty with a CT-based navigation system.

Nakahara I, Kyo T, Kuroda Y, Miki H.

J Artif Organs. 2018 Sep;21(3):340-347. doi: 10.1007/s10047-018-1041-6. Epub 2018 Apr 2.

PMID:
29611147
2.

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study.

Tojo A, Kyo T, Yamamoto K, Nakamae H, Takahashi N, Kobayashi Y, Tauchi T, Okamoto S, Miyamura K, Hatake K, Iwasaki H, Matsumura I, Usui N, Naoe T, Tugnait M, Narasimhan NI, Lustgarten S, Farin H, Haluska F, Ohyashiki K.

Int J Hematol. 2017 Sep;106(3):385-397. doi: 10.1007/s12185-017-2238-9. Epub 2017 Apr 25.

PMID:
28444644
3.

Post-allogeneic stem cell transplant extramedullary relapse of acute megakaryoblastic leukemia initially detected by elevated WT1 mRNA levels in peripheral blood.

Ochi T, Iwato K, Katayama Y, Toishigawa K, Okatani T, Imanaka R, Kyo K, Itagaki M, Katsutani S, Asaoku H, Kyo T.

Rinsho Ketsueki. 2016;57(11):2319-2323. Japanese.

PMID:
27941279
4.

Prognostic Significance of New-Onset Atrial Fibrillation in Patients With Non-Hodgkin's Lymphoma Treated With Anthracyclines.

Amioka M, Sairaku A, Ochi T, Okada T, Asaoku H, Kyo T, Kihara Y.

Am J Cardiol. 2016 Nov 1;118(9):1386-1389. doi: 10.1016/j.amjcard.2016.07.049. Epub 2016 Aug 12.

PMID:
27600461
5.

High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.

Nakase K, Kita K, Kyo T, Katayama N.

Leuk Lymphoma. 2017 May;58(5):1268-1270. doi: 10.1080/10428194.2016.1236377. Epub 2016 Oct 13. No abstract available.

PMID:
27736287
6.

Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemia.

Kadono M, Kanai A, Nagamachi A, Shinriki S, Kawata J, Iwato K, Kyo T, Oshima K, Yokoyama A, Kawamura T, Nagase R, Inoue D, Kitamura T, Inaba T, Ichinohe T, Matsui H.

Exp Hematol. 2016 Aug;44(8):745-754.e4. doi: 10.1016/j.exphem.2016.04.017. Epub 2016 May 9.

PMID:
27174803
7.

Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation.

Nomura S, Maeda Y, Ishii K, Katayama Y, Yagi H, Fujishima N, Ota S, Moriyama M, Ikezoe T, Miyazaki Y, Hayashi K, Fujita S, Satake A, Ito T, Kyo T, Tanimoto M.

J Blood Med. 2016 Jan 18;7:1-4. doi: 10.2147/JBM.S93008. eCollection 2016.

8.

Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.

Nakase K, Kita K, Kyo T, Ueda T, Tanaka I, Katayama N.

PLoS One. 2015 Sep 16;10(9):e0128998. doi: 10.1371/journal.pone.0128998. eCollection 2015.

9.

Effects of coordinate-system construction methods on postoperative computed tomography evaluation of implant orientation after total hip arthroplasty.

Kyo T, Nakahara I, Kuroda Y, Miki H.

Comput Aided Surg. 2015;20(1):52-60. doi: 10.3109/10929088.2015.1076047. Epub 2015 Aug 20.

PMID:
26290170
10.

Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients.

Nakae Y, Oka Y, Fujiki F, Morimoto S, Kamiya T, Takashima S, Nakata J, Nishida S, Nakajima H, Hosen N, Tsuboi A, Kyo T, Oji Y, Mizuguchi K, Kumanogoh A, Sugiyama H.

Cancer Immunol Immunother. 2015 Jul;64(7):791-804. doi: 10.1007/s00262-015-1683-7. Epub 2015 Apr 3.

PMID:
25835542
11.

Risk of edge-loading and prosthesis impingement due to posterior pelvic tilting after total hip arthroplasty.

Miki H, Kyo T, Kuroda Y, Nakahara I, Sugano N.

Clin Biomech (Bristol, Avon). 2014 Jun;29(6):607-13. doi: 10.1016/j.clinbiomech.2014.05.002. Epub 2014 May 21.

PMID:
24933660
12.

Factors predicting change in pelvic posterior tilt after THA.

Kyo T, Nakahara I, Miki H.

Orthopedics. 2013 Jun;36(6):e753-9. doi: 10.3928/01477447-20130523-20.

PMID:
23746037
13.

The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.

Kako S, Morita S, Sakamaki H, Iida H, Kurokawa M, Miyamura K, Kanamori H, Hara M, Kobayashi N, Morishima Y, Kawa K, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y.

Bone Marrow Transplant. 2013 Aug;48(8):1077-83. doi: 10.1038/bmt.2013.4. Epub 2013 Feb 4.

PMID:
23376818
14.

High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: correlation with poor prognosis and CD4 expression on blast cells.

Nakase K, Kita K, Kyo T, Tsuji K, Katayama N.

Cancer Epidemiol. 2012 Oct;36(5):e306-9. doi: 10.1016/j.canep.2012.03.011. Epub 2012 Apr 24.

PMID:
22537764
15.

Anatomical hip range of motion after implantation during total hip arthroplasty with a large change in pelvic inclination.

Miki H, Kyo T, Sugano N.

J Arthroplasty. 2012 Oct;27(9):1641-1650.e1. doi: 10.1016/j.arth.2012.03.002. Epub 2012 Apr 20.

PMID:
22521398
16.

Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia.

Takahashi N, Kyo T, Maeda Y, Sugihara T, Usuki K, Kawaguchi T, Usui N, Okamoto S, Ohe Y, Ohtake S, Kitamura K, Yamamoto M, Teshima H, Motoji T, Tamaki T, Sawada K, Ohyashiki K.

Haematologica. 2012 Jun;97(6):903-6. doi: 10.3324/haematol.2011.056853. Epub 2011 Dec 16.

17.

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease.

Tsuboi A, Oka Y, Kyo T, Katayama Y, Elisseeva OA, Kawakami M, Nishida S, Morimoto S, Murao A, Nakajima H, Hosen N, Oji Y, Sugiyama H.

Leukemia. 2012 Jun;26(6):1410-3. doi: 10.1038/leu.2011.343. Epub 2011 Dec 13. No abstract available.

PMID:
22157809
18.

Increased natural killer cells and decreased CD3(+)CD8(+)CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.

Ohyashiki K, Katagiri S, Tauchi T, Ohyashiki JH, Maeda Y, Matsumura I, Kyo T.

Br J Haematol. 2012 Apr;157(2):254-6. doi: 10.1111/j.1365-2141.2011.08939.x. Epub 2011 Nov 11. No abstract available.

PMID:
22077498
19.

Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?

Nakase K, Suzuki K, Kyo T, Kohara T, Sugawara Y, Katayama N.

Int J Infect Dis. 2012 Jan;16(1):e2-e4. doi: 10.1016/j.ijid.2011.09.017. Epub 2011 Nov 8.

20.

[Successful completion of left total hip arthroplasty by inhibitor neutralization therapy in a hemophilia B patient with high responding inhibitor].

Ogawa Y, Nishida Y, Kyo T, Miki H, Yonemoto H, Bandou H, Yajima K, Kasai D, Taniguchi T, Watanabe D, Uehira T, Ueda T, Shirasaka T.

Rinsho Ketsueki. 2011 Aug;52(8):713-7. Japanese.

PMID:
21897080
21.

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.

Kako S, Morita S, Sakamaki H, Ogawa H, Fukuda T, Takahashi S, Kanamori H, Onizuka M, Iwato K, Suzuki R, Atsuta Y, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y.

Leukemia. 2011 Feb;25(2):259-65. doi: 10.1038/leu.2010.260. Epub 2010 Nov 12.

PMID:
21072046
22.

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study.

Jinnai I, Sakura T, Tsuzuki M, Maeda Y, Usui N, Kato M, Okumura H, Kyo T, Ueda Y, Kishimoto Y, Yagasaki F, Tsuboi K, Horiike S, Takeuchi J, Iwanaga M, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Ohno R.

Int J Hematol. 2010 Oct;92(3):490-502. doi: 10.1007/s12185-010-0672-z. Epub 2010 Sep 10.

PMID:
20830614
23.

Fatal Trichosporon fungemia in patients with hematologic malignancies.

Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y, Shibazaki T, Oka K, Tsukada T, Katayama N.

Eur J Haematol. 2010 May;84(5):441-7. doi: 10.1111/j.1600-0609.2010.01410.x. Epub 2010 Jan 13.

PMID:
20059528
24.

Intra-articular distal ulnar fractures associated with distal radial fractures in older adults: early experience in fixation of the radius and leaving the ulna unfixed.

Namba J, Fujiwara T, Murase T, Kyo T, Satoh I, Tsuda T.

J Hand Surg Eur Vol. 2009 Oct;34(5):592-7. doi: 10.1177/1753193409103728. Epub 2009 Aug 17.

PMID:
19687083
25.

[Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].

Yagasaki F, Niwa T, Abe A, Ishikawa M, Kato C, Ogura K, Sasaki H, Kyo T, Jinnai I, Bessyo M, Miyamura K.

Rinsho Ketsueki. 2009 Jun;50(6):481-7. Japanese.

PMID:
19571508
26.

[Photodynamic therapy in age-related macular degeneration: one-year results].

Ohira-Tochigi K, Yokoyama E, Matsumoto Y, Kyo T, Yuzawa M.

Nippon Ganka Gakkai Zasshi. 2008 Oct;112(10):855-62. Japanese.

PMID:
18949910
27.

[Assessment of the quality of life in patients with age-related macular degeneration 1 year after photodynamic therapy].

Kyo T, Yuzawa M, Tochigi K, Yamaguchi T, Shimozuma K, Fukuhara S, Matsumoto Y.

Nippon Ganka Gakkai Zasshi. 2007 Apr;111(4):315-21. Japanese.

PMID:
17461036
29.

Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis.

Nakase K, Kita K, Miwa H, Nishii K, Shikami M, Tanaka I, Tsutani H, Ueda T, Nasu K, Kyo T, Dohy H, Shiku H, Katayama N.

Leukemia. 2007 Feb;21(2):326-32. Epub 2007 Jan 4.

PMID:
17205058
30.

[Assessment of the quality of life of patients with age-related macular degeneration after photodynamic therapy].

Kyo T, Matsumoto Y, Tochigi K, Yuzawa M, Yamaguchi T, Komoto A, Shimozuma K, Fukuhara S.

Nippon Ganka Gakkai Zasshi. 2006 Sep;110(9):710-6. Japanese.

PMID:
17025228
31.

[Clinical effects of photodynamic therapy with Verteporfin for age-related macular degeneration 1: three-month results].

Tochigi K, Matsumoto Y, Kyo T, Yamaguchi T, Komoto A, Yuzawa M, Shimotsuma K, Fukuhara S.

Nippon Ganka Gakkai Zasshi. 2006 Sep;110(9):703-9. Japanese.

PMID:
17025227
32.

Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.

Niimi H, Harada H, Harada Y, Ding Y, Imagawa J, Inaba T, Kyo T, Kimura A.

Leukemia. 2006 Apr;20(4):635-44.

PMID:
16467864
33.

Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.

Hiramatsu A, Miwa H, Shikami M, Ikai T, Tajima E, Yamamoto H, Imai N, Hattori A, Kyo T, Watarai M, Miura K, Satoh A, Itoh M, Imamura A, Mihara H, Katoh Y, Nitta M.

Leuk Lymphoma. 2006 Jan;47(1):89-95.

PMID:
16465716
35.

Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression.

Shikami M, Miwa H, Nishii K, Kyo T, Tanaka I, Shiku H, Kita K, Nitta M.

Leuk Res. 2006 Apr;30(4):379-83. Epub 2005 Sep 12.

PMID:
16162359
37.

Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol.

Mukai Y, Yoshida T, Nakaike R, Mukai N, Iwato K, Kyo T, Kaseda S.

Intern Med. 2004 Nov;43(11):1087-8.

38.

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, Elisseeva OA, Oji Y, Kawakami M, Ikegame K, Hosen N, Yoshihara S, Wu F, Fujiki F, Murakami M, Masuda T, Nishida S, Shirakata T, Nakatsuka S, Sasaki A, Udaka K, Dohy H, Aozasa K, Noguchi S, Kawase I, Sugiyama H.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13885-90. Epub 2004 Sep 13.

39.

Effect of interferon-alpha on chromosome abnormalities in treated chronic myelogenous leukemia patients.

Tanaka H, Tanaka K, Oguma N, Ito K, Ito T, Kyo T, Dohy H, Kimura A.

Cancer Genet Cytogenet. 2004 Sep;153(2):133-43.

PMID:
15350303
40.

Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with micro-BCR-ABL (e19a2) transcript.

Ito T, Tanaka H, Tanaka K, Ito K, Kyo T, Dohy H, Kamada N, Kimura A.

Br J Haematol. 2004 Sep;126(5):752-3. No abstract available.

PMID:
15327531
41.
42.
43.

Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.

Liu LG, Tanaka H, Ito K, Kyo T, Ito T, Kimura A.

Am J Hematol. 2003 Dec;74(4):268-72. Review.

44.

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.

Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T.

Blood. 2004 Mar 15;103(6):2316-24. Epub 2003 Nov 13.

45.
46.

PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.

Ikezoe T, Chen S, Saito T, Asou H, Kyo T, Tanosaki S, Heber D, Taguchi H, Koeffler HP.

Int J Oncol. 2003 Oct;23(4):1203-11.

PMID:
12964005
47.

Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.

Myoken Y, Kyo T, Kohara T, Fujihara M, Sugata T, Mikami Y.

Clin Infect Dis. 2003 Jun 1;36(11):1496-7. No abstract available.

PMID:
12766847
48.

Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.

Nishii K, Usui E, Katayama N, Lorenzo F 5th, Nakase K, Kobayashi T, Miwa H, Mizutani M, Tanaka I, Nasu K, Dohy H, Kyo T, Taniwaki M, Ueda T, Kita K, Shiku H.

Leukemia. 2003 Apr;17(4):731-7.

PMID:
12682630
50.

Molecular epidemiology of invasive stomatitis due to Aspergillus flavus in patients with acute leukemia.

Myoken Y, Sugata T, Fujita Y, Kyo T, Fujihara M, Kohara T, Katsu M, Mikami Y.

J Oral Pathol Med. 2003 Apr;32(4):215-8.

PMID:
12653860

Supplemental Content

Support Center